Xuan Ming

Xuan Ming

Auto-generated profile, based on publicly available information

Xuan Ming

National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
NWNan Wu
Nan Wu
XMXuan Ming
Xuan Ming
JXJianqiu Xiao
Jianqiu Xiao
ZWZhihong Wu
Zhihong Wu
XCXiaoli Chen
Xiaoli Chen
FZFeng Zhang
Feng Zhang
Congenital scoliosis is a common type of vertebral malformation. Genetic susceptibility has been implicated in congenital scoliosis. We evaluated 161 Han Chinese persons with sporadic congenital scoliosis, 166 Han Chinese controls, and 2 pedigrees, family members of which had a 16p11.2 deletion, using comparative genomic hybridization, quantitative polymerase-chain-reaction analysis, and DNA sequencing. We carried out tests of replication using an additional series of 76 Han Chinese persons with congenital scoliosis and a multicenter series of 42 persons with 16p11.2 deletions. We identified a total of 17 heterozygous TBX6 null mutations in the 161 persons with sporadic congenital scoliosis (11%); we did not observe any null mutations in TBX6 in 166 controls (P<3.8×10−6). These null alleles include copy-number variants (12 instances of a 16p11.2 deletion affecting TBX6) and single-nucleotide variants (1 nonsense and 4 frame-shift mutations). However, the discordant intrafamilial phenotypes of 16p11.2 deletion carriers suggest that heterozygous TBX6 null mutation is insufficient to cause congenital scoliosis. We went on to identify a common TBX6 haplotype as the second risk allele in all 17 carriers of TBX6 null mutations (P<1.1×10−6). Replication studies involving additional persons with congenital scoliosis who carried a deletion affecting TBX6 confirmed this compound inheritance model. In vitro functional assays suggested that the risk haplotype is a hypomorphic allele. Hemivertebrae are characteristic of TBX6-associated congenital scoliosis. Compound inheritance of a rare null mutation and a hypomorphic allele of TBX6 accounted for up to 11% of congenital scoliosis cases in the series that we analyzed. (Funded by the National Basic Research Program of China and others.)

24 June 2020 in Cell Research
Verified
Journal Article
Closed access
PDF file
XMXuan Ming
Xuan Ming
ZZZhuqiang Zhang
Zhuqiang Zhang
ZZZhuoning Zou
Zhuoning Zou
CLCong Lv
Cong Lv
QDQiang Dong
Qiang Dong
BZBing Zhu
Bing Zhu

20 July 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
QWQiujun Wang
Qiujun Wang
GYGuang Yu
Guang Yu
XMXuan Ming
Xuan Ming
WXWeikun Xia
Weikun Xia
XXXiguang Xu
Xiguang Xu
WXWei Xie
Wei Xie

1 January 2021 in Journal of Genetics and Genomics
Verified
Journal Article
Closed access
XMXuan Ming
Xuan Ming
BZBing Zhu
Bing Zhu
YLYingfeng Li
Yingfeng Li


1 October 2008 in Chinese Medical Journal
Verified
Journal Article
Open access
SYSen Yang
Sen Yang
XWXiao-Yi Wang
Xiao-Yi Wang
LGLi-Juan Guo
Li-Juan Guo
XTXiu-Fa Tang
Xiu-Fa Tang
QGQing-Hong Gao
Qing-Hong Gao
YCYu-Tang Cao
Yu-Tang Cao
Researchers have recently demonstrated that thrombospondin-1 (TSP-1) has an important function in regulating neovascularization. Whether it inhibits or accelerates neovascularization, however, is still controversial. We found few reports about the correlation between TSP-1 and vascularization in mucoepidermoid carcinoma. In this research, the distribution and expression of TSP-1 in mucoepidermoid carcinoma were investigated. We also analyzed (1) the correlation between the expression of TSP-1 and microvessel density (MVD), as an indicator of neovascularization activity, and (2) the effect of TSP-1 on neovascularization and tumor growth in the subcutaneous xenotransplanted model of mucoepidermoid carcinoma. (1) The sites and intensity of expression of TSP-1 and the MVD were analyzed in 45 cases of mucoepidermoid carcinoma after surgery by the method of streptavidin-peroxidase (SP) immunohistochemistry; and (2) recombinant human thrombospondin-1 (rhTSP-1) was injected twice a week for five consecutive weeks around the tumor in the subcutaneous xenotransplanted tumor model of mucoepidermoid carcinoma in nude mice. Each week, the tumor size was measured, in order to draw the growth curve of the xenotransplanted tumor model of mucoepidermoid carcinoma, and MVD was measured. (1) The positive expression of TSP-1 protein was 57.78% (26/45). Most positive staining for TSP-1 was found in the cytoplasm of the cancer cells, while some staining occurred in the extracellular matrix. The mean MVD in 45 cases of mucoepidermoid carcinoma was 58.17±19.77 per 100 visual fields. Tumors with a high expression of TSP-1 showed a low MVD value, and the TSP-1 immunocompetence and microvessel density showed a significant negative correlation (r s=-0.947, P <0.001). (2) The xenotransplanted tumors with the injection doses of 1.25, 0.75 and 0.25 μg/ml respectively were 36.97%, 53.36% and 73.61% of the size of the control group ((451±92), (651±113), (898±86) and (1220±157) mm3 respectively, F=53.167, P <0.001), and their weights were respectively 35.14%, 51.35% and 70.27% of the control group ((1.3±0.5), (1.9±0.5), (2.6±0.3), and (3.7±0.7) g respectively, F=62.669, P <0.001). Their MVDs were 25.00%, 45.93%, and 72.20% respectively of the control group and concentration dependent (15.43±3.45, 28.35±4.24, 44.57±3.35 and 61.73±5.43 per 100 visual fields respectively, F=54.582, P<0.001). The TSP-1 has a higher expression in mucoepidermoid carcinoma and the expression has a significant negative correlation with neovascularization. The TSP-1 inhibits neovascularization and tumor growth, and it might be a new biological therapy for treatment of patients with mucoepidermoid carcinoma.